Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Turkey's central bank held its key policy rate at 37% and left overnight rates unchanged, citing geopolitical uncertainty from the Iran war and elevated, volatile energy prices that could alter the inflation trajectory. The bank signalled vigilance for second-round inflation effects even as market expectations shift and Reuters polling shows most e…
Citi Research says the UK government's recent moves to curb gas-driven electricity prices will probably not lower power costs materially. The broker argued that raising the Electricity Generator Levy (EGL) rate while leaving the £75/MWh threshold in place, combined with a voluntary Contracts for Difference (CfD) plan lacking key details, will fail …
Caliber is progressing its Hyatt Studios hotel development platform across three U.S. markets—Steamboat Springs, Colorado; Riverwalk/Scottsdale, Arizona; and Georgetown, Texas—with plans to open the first hotel in late 2027. The developments capitalize on constrained supply and strong extended-stay demand, leveraging Hyatt's brand and aiming to tra…
Merck & Co announced a multiyear partnership with Google Cloud to accelerate artificial intelligence adoption across its drug development, regulatory, manufacturing and commercial operations. The drugmaker said it could invest as much as $1 billion over several years to fund AI infrastructure, engineering collaboration and licensing of Google’s Gem…
France’s statutory fiscal watchdog said on Wednesday that uncertain economic conditions and possible interest rate changes threaten the government’s plan to reduce the budget deficit to 3% of output by 2029. Rising energy costs linked to the Middle East conflict have altered macro projections, prompting the finance ministry to trim 2026 growth fore…
Philip Morris International trimmed its full-year adjusted earnings-per-share outlook amid mounting competition in nicotine pouch products and regulatory uncertainty surrounding its Zyn line. The company reported first-quarter revenue and adjusted EPS above consensus and said it had incorporated limited impacts from the Middle East conflict into it…
Balchem Corporation has released its 2025 Sustainability Report highlighting significant progress including surpassing its 2030 greenhouse gas reduction target early by achieving a 31% decrease in Scope 1 and 2 emissions, reducing water withdrawal by 16%, and reinforcing commitments to the UN Global Compact and Sustainable Development Goals. The co…
Shipping executives at the FT Commodities Global Summit said Asian shipowners, including government-linked fleets, are more likely to restart voyages through the Strait of Hormuz before Western companies. The imbalance reflects differing tolerance for sanctions risk, access to government-to-government channels, and the prospect of Iranian tolls and…
The head of the Gas Exporting Countries Forum cautioned that the temporary demand destruction for natural gas triggered by the Iran war could become structural if the conflict endures. Since the crisis began late in February, over 500 million barrels of crude and condensate have been removed from global markets, prompting some gas-importing countri…
European utilities have outperformed the broader market in 2026, with battery storage and renewables names driving gains. UBS analysts argue the sector has room to run after multiple recovery and stronger earnings growth, and they single out RWE, Orsted and Grenergy as preferred holdings. The bank also highlights exposure risks in National Grid, Ve…
MGM offers a way to play potential upside from an Osaka expansion and broader international recovery while sitting on meaningful free cash flow and attractive EV multiples. The trade uses a disciplined entry at $39.40, a $34 stop, and a $48 target over a 180 trading-day horizon.
NovaBridge Biosciences announced the appointment of Mark Hagler as President and Chief Commercial Officer. Hagler brings over 25 years of commercial leadership experience in biopharma, particularly in oncology and ophthalmology, and will drive corporate strategy, clinical trial design, and business development. The appointment supports the advancem…
Fidelity D & D Bancorp, Inc. announced strong first quarter 2026 financial results, with net income rising 25% to $7.5 million compared to the same period last year. This growth was primarily due to a $2.4 million increase in net interest income from loan portfolio and deposit growth, improved net interest margins, and a 4% increase in non-interest…
Jade Biosciences, a Nasdaq-listed clinical-stage biotech company focused on autoimmune disease therapies, announced the appointment of Dr. Edward R. Conner as Chief Medical Officer. Dr. Conner brings extensive experience in clinical development and regulatory strategy, supporting Jade's advancement of its pipeline including JADE101, JADE201, and JA…
NRx Pharmaceuticals announced a positive Discipline Review Letter from the FDA Office of Generic Drugs for its preservative-free ketamine Abbreviated New Drug Application (ANDA). FDA leadership expressed support for expediting approval within the current review cycle, targeting Summer 2026, in alignment with a recent Executive Order prioritizing ra…
Keel Infrastructure Corp. completed the sale of its 70 MW site in Paso Pe, Paraguay, for approximately $13 million, reflecting current challenges in the Bitcoin mining sector and broader macroeconomic factors. This divestment marks Keel's full exit from Latin America, leaving a 100% North American portfolio. The company plans to invest the proceeds…
Picard Medical, Inc., parent company of SynCardia Systems, reported a 79.9% increase in revenue to $1.1 million for Q1 2026, driven by higher sales and utilization of its SynCardia Total Artificial Heart (STAH) and increased driver rental income. Favorable reimbursement and economic conditions in the U.S., alongside pricing adjustments in rental pr…
Stifel Financial Corp. announced record first quarter 2026 results, with net revenues of $1.48 billion, a 17.7% increase year-over-year, and net income available to common shareholders of $242.1 million, or $1.48 per diluted share, significantly higher than the prior year. Growth was driven by higher investment banking, asset management, and transa…
Rogers Communications delivered 10% year-over-year growth in total service revenue to $4.9 billion and 5% growth in adjusted EBITDA to $2.4 billion in Q1 2026. The company posted strong free cash flow growth of 32% to $776 million and improved its debt leverage ratio to 3.8x. Wireless and Cable segments showed EBITDA growth with subscriber addition…
Old National Bancorp reported strong Q1 2026 results including net income of $229.6 million and diluted EPS of $0.59, reflecting solid loan growth, improved capital ratios, and effective expense control. Key highlights include an 8.0% annualized loan growth, improved deposits, stable credit quality, and ongoing capital returns through share repurch…
Advantage Solutions Inc. announced that it will release its first quarter 2026 financial results on May 6, 2026, with a follow-up conference call to discuss the results. The company is a leading omnichannel retail solutions agency in North America serving CPG brands and retailers with data-driven services to optimize demand generation and product d…
Rogers Communications Inc. declared a quarterly dividend of 50 cents per share on both its Class A Voting shares and Class B Non-Voting shares, payable on July 6, 2026, to shareholders of record on June 9, 2026. The announcement underscores the company's commitment to returning value to investors.
SAB Biotherapeutics reported encouraging Phase 1 clinical trial results for SAB-142, its fully human anti-thymocyte globulin immunotherapy aimed at type 1 diabetes (T1D). The trial demonstrated C-peptide preservation and improved glycemic control in adult T1D participants, with most showing a 'super responder' profile linked to T cell exhaustion. T…
Aurora Mobile Limited (NASDAQ: JG) highlighted its AI-first customer engagement platform, EngageLab, at Japan's leading AI expo, NexTech Week Tokyo Spring 2026. The platform demonstrated integrated AI orchestration capabilities enabling autonomous execution of business processes across various communication channels, targeting key Japanese industri…
Ligand Pharmaceuticals, a Nasdaq-listed biopharmaceutical royalty aggregator, will release its first quarter 2026 financial results on May 7, 2026, followed by a conference call to discuss performance and provide a business update. The company manages a diverse portfolio of royalty interests and licenses proprietary drug development technologies.
